Certain factors make it challenging to conduct value assessments on services and procedures, including the lack of randomized clinical trial evidence, which can make measurement of effectiveness ...
Value allocation decisions for curative gene therapies cannot be divorced from value assessment. We propose a three-step framework of interrelated value questions, which together have important ...